Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy

Diabetic Medicine

Volumn 24, Issue 12, 2007, Pages 1386-1392

  Yang, Y H ^b   Zhang, S ^b   Cui, J F ^c   Lu, B ^b   Dong, X H ^b   Song, X Y ^b   Liu, Y K ^c   Zhu, X X ^b   Hu, R M ^a,b  

^a Fudan University ^*  (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Decision tree; Diabetic nephropathy; Fingerprint profile; Proteinchip; Proteomics; SELDI MS TOF

Indexed keywords

CREATININE; PLASMA PROTEIN;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; CREATININE URINE LEVEL; DECISION TREE; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN MICROARRAY; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PROTEINS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOME; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 36549045997     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02312.x     Document Type: Article

References (28)

1. Craig KJ, Donovan K, Munnery M, Owens DR, Williams JD, Phillips AO. Identification and management of diabetic nephropathy in the diabetes clinic. Diabetes Care 2003 26 : 1806 1811.
2. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005 28 : 164 176.
3. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004 27 (Suppl 1 S79 S83.
4. Thorp ML. Diabetic nephropathy: common questions. Am Fam Physician 2005 72 : 96 99.
5. Kallner A, Estonius M. Are there advantages with U-Albumin/U-Creatinine ratios compared with U-Albumin in monitoring diabetes? Scand J Clin Lab Invest 2005 65 : 439 445.
6. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984 310 : 356 360.
7. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH. Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant 2001 16 : 2337 2347.
8. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int 2000 58 : 1719 1731.
9. Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992 41 : 758 762.
10. Gross ML, Dikow R, Ritz E. Diabetic nephropathy. Recent insights into the pathophysiology and the progression of diabetic nephropathy. Kidney Int 2005 94 (Suppl S50 S53.
11. Hryciw DH, Lee EM, Pollock CA, Poronnik P. Molecular changes in proximal tubule function in diabetes mellitus. Clin Exp Pharmacol Physiol 2004 31 : 372 379.
12. Banez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL et al. Diagnostic potential of serum proteomic patterns in prostate cancer. J Urol 2003 170 : 442 446.
13. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002 359 : 572 577.
14. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002 48 : 1296 1304.
15. Xiao XY, Tang Y, Wei XP, He DC. A preliminary analysis of non-small cell lung cancer biomarkers in serum. Biomed Environ Sci 2003 16 : 140 148.
16. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002 62 : 3609 3614.
17. Hansen HP, Hovind P, Jensen BR, Parving HH. Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy. Kidney Int 2002 61 : 163 168.
18. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000 49 : 1399 1408.
19. Narita T, Sasaki H, Hosoba M, Miura T, Yoshioka N, Morii T et al. Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Diabetes Care 2004 27 : 1176 1181.
20. Hong CY, Hughes K, Chia KS, Ng V, Ling SL. Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore. Diabetes Care 2003 26 : 338 342.
21. Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications 1998 12 : 43 60.
22. Sharma K, Lee S, Han S, Lee S, Francos B, McCue P et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005 5 : 2648 2655.
23. Aksun SA, Ozmen D, Ozmen B, Parildar Z, Mutaf I, Turgan N et al. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2004 112 : 195 200.
24. Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care, 2005 28 : 2890 2895.
25. Mojiminiyi OA, Abdella N, George S. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest 2000 60 : 483 489.
26. Li L, Tang H, Wu Z, Gong J, Gruidl M, Zou J et al. Data mining techniques for cancer detection using serum proteomic profiling. Artif Intell Med 2004 32 : 71 83.
27. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2003 2 : 1096 1103.
28. Xiao Z, Prieto D, Conrads TP, Veenstra TD, Issaq HJ. Proteomic patterns: their potential for disease diagnosis. Mol Cell Endocrinol 2005 230 : 95 106.